Allows pharmaceutical companies to communicate off-label treatment uses to health care professionals
Bill status
in committee
1 of 4 stages cleared
Introduction
Dec 2017
Committee Review
Floor Vote
Governor
Introduced Dec 6, 2017
Last action Apr 26, 2018
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
12
Key actions
0
Committee
6
Apr 26, 2018
Legislature · Reported by committee
Reported Do Pass (H) - AYES: 8 NOES: 0 PRESENT: 0
Apr 25, 2018
Legislature · Reported by committee
Voted Do Pass (H)
Apr 17, 2018
Legislature · Referred to committee
Referred: Rules - Administrative Oversight(H)
Apr 17, 2018
Legislature · Reported by committee
HCS Reported Do Pass (H) - AYES: 9 NOES: 0 PRESENT: 0
Apr 11, 2018
Legislature · Reported by committee
HCS Voted Do Pass (H)
Jan 24, 2018
Legislature · Referred to committee
Referred: Health and Mental Health Policy(H)
Dec 6, 2017
Legislature · Introduced
Prefiled (H)
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1524
Scope: MO
Hi! I can help you understand HB 1524. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline